The invention relates to (among other things) oligomer-containing hydantoin compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits one or more advantages over corresponding compounds lacking the oligomer.
本发明涉及含寡聚物的
脲嘧啶化合物(除其他外)。本发明的一种化合物,在通过任何一种给药途径给予时,表现出比缺乏寡聚物的相应化合物更多的优点。